Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study
CompletedOBSERVATIONAL
Enrollment
4,000
Participants
Timeline
Start Date
January 31, 2017
Primary Completion Date
June 30, 2017
Study Completion Date
June 30, 2017
Conditions
T2DM (Type 2 Diabetes Mellitus)Fatty LiverNAFLD
Interventions
OTHER
Non-interventional
Trial Locations (1)
L6S 0C9
LMC Brampton, Brampton
All Listed Sponsors
lead
LMC Diabetes & Endocrinology Ltd.
OTHER
NCT03233178 - Measurement of Alanine Aminotransaminase (ALT) Following Initiation of Antidiabetic Agents in Patients With Type 2 Diabetes in a Real-world Clinical Setting: a Retrospective Cohort Study | Biotech Hunter | Biotech Hunter